HSBC Holdings’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-21,517
| Closed | -$311K | – | 3027 |
|
|
2026
Q1 | $311K | Buy |
+21,517
| New | +$308K | ﹤0.01% | 2436 |
|
|
2025
Q3 | – | Sell |
-65,044
| Closed | -$377K | – | 2851 |
|
|
2025
Q2 | $377K | Buy |
65,044
+14,588
| +29% | +$94.1K | ﹤0.01% | 2308 |
|
|
2025
Q1 | $412K | Buy |
50,456
+8,536
| +20% | +$79K | ﹤0.01% | 2181 |
|
|
2024
Q4 | $395K | Buy |
41,920
+18,964
| +83% | +$197K | ﹤0.01% | 2320 |
|
|
2024
Q3 | $247K | Sell |
22,956
-8,317
| -27% | -$90.6K | ﹤0.01% | 2479 |
|
|
2024
Q2 | $308K | Buy |
31,273
+809
| +3% | +$8.3K | ﹤0.01% | 2258 |
|
|
2024
Q1 | $359K | Buy |
+30,464
| New | +$390K | ﹤0.01% | 2308 |
|
|
2021
Q3 | – | Sell |
-10,340
| Closed | -$102K | – | 3041 |
|
|
2021
Q2 | $102K | Buy |
+10,340
| New | +$101K | ﹤0.01% | 2846 |
|
|
2021
Q1 | – | Sell |
-33,262
| Closed | -$772K | – | 2862 |
|
|
2020
Q4 | $772K | Buy |
+33,262
| New | +$680K | ﹤0.01% | 1882 |
|
|
2020
Q3 | – | Sell |
-12,667
| Closed | -$191K | – | 2768 |
|
|
2020
Q2 | $191K | Buy |
+12,667
| New | +$154K | ﹤0.01% | 2383 |
|
|
2020
Q1 | – | Sell |
-25,220
| Closed | -$247K | – | 2811 |
|
|
2019
Q4 | $247K | Sell |
25,220
-21,285
| -46% | -$195K | ﹤0.01% | 2692 |
|
|
2019
Q3 | $373K | Buy |
+46,505
| New | +$505K | ﹤0.01% | 2494 |
|
|
2018
Q2 | – | Sell |
-133,594
| Closed | -$2.01M | – | 2612 |
|
|
2018
Q1 | $2.01M | Buy |
+133,594
| New | +$2.03M | ﹤0.01% | 1424 |
|
|
2017
Q1 | – | Sell |
-24,543
| Closed | -$122K | – | 2272 |
|
|
2016
Q4 | $122K | Buy |
+24,543
| New | +$170K | ﹤0.01% | 2602 |
|
Other funds holding FOLD
HSBC Holdings's FOLD Position: Q2 2026 in Review
HSBC Holdings sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 21,517 shares — an estimated $311K sold.
HSBC Holdings first reported a position in FOLD in Q4 2016 and held it in 14 quarters. The position peaked at $2.01M in Q1 2018. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- HSBC Holdings reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- HSBC Holdings sold 21,517 Amicus Therapeutics shares in Q2 2026, an estimated $311K.
- HSBC Holdings first reported a position in Amicus Therapeutics in Q4 2016 and held it in 14 quarters.
- HSBC Holdings's Amicus Therapeutics position peaked at $2.01M in Q1 2018.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.